These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16036306)

  • 1. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.
    Göppert TM; Müller RH
    J Drug Target; 2005 Apr; 13(3):179-87. PubMed ID: 16036306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
    Göppert TM; Müller RH
    Eur J Pharm Biopharm; 2005 Aug; 60(3):361-72. PubMed ID: 15996577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
    Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.
    Blunk T; Hochstrasser DF; Sanchez JC; Müller BW; Müller RH
    Electrophoresis; 1993 Dec; 14(12):1382-7. PubMed ID: 8137807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.
    Kreuter J; Ramge P; Petrov V; Hamm S; Gelperina SE; Engelhardt B; Alyautdin R; von Briesen H; Begley DJ
    Pharm Res; 2003 Mar; 20(3):409-16. PubMed ID: 12669961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
    Girotra P; Singh SK
    Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.
    Gessner A; Olbrich C; Schröder W; Kayser O; Müller RH
    Int J Pharm; 2001 Feb; 214(1-2):87-91. PubMed ID: 11282243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.
    Göppert TM; Müller RH
    Int J Pharm; 2005 Sep; 302(1-2):172-86. PubMed ID: 16098695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative sample preparation prior to two-dimensional electrophoresis protein analysis on solid lipid nanoparticles.
    Göppert TM; Müller RH
    Electrophoresis; 2004 Jan; 25(1):134-40. PubMed ID: 14730578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of apolipoproteins on dalargin transport across the blood-brain barrier.
    Shamenkov DA; Petrov VE; Alyautdin RN
    Bull Exp Biol Med; 2006 Dec; 142(6):703-6. PubMed ID: 17603675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
    Kasongo KW; Jansch M; Müller RH; Walker RB
    J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles.
    Göppert TM; Müller RH
    J Drug Target; 2003 May; 11(4):225-31. PubMed ID: 14578109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
    Olbrich C; Gessner A; Schröder W; Kayser O; Müller RH
    J Control Release; 2004 May; 96(3):425-35. PubMed ID: 15120899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.
    Kurakhmaeva KB; Voronina TA; Kapica IG; Kreuter J; Nerobkova LN; Seredenin SB; Balabanian VY; Alyautdin RN
    Bull Exp Biol Med; 2008 Feb; 145(2):259-62. PubMed ID: 19023984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
    Bagad M; Khan ZA
    Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
    Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
    J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.